Medivation

After XTANDI's FDA Approval, Medivation Pulls Back
Seeking Alpha
Sat, 11/17/12 - 01:44 pm
Xtandi
Medivation
prostate cancer
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
prostate cancer
Medivation
Dendreon
Provenge
JNJ
Sanofi
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Xtandi
Zytiga
prostate cancer
JNJ
Medivation
Astellas
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
biotech
M&A
Amarin
Achillion
ONYX Pharmaceuticals
Actelion
Elan
Forest Labs
Medivation
Biomarin
Indenix
Medivation Prostate Cancer Drug Launches Hot
TheStreet.com
Thu, 11/1/12 - 11:50 am
Medivation
prostate cancer
Astellas
Xtandi
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Sun, 09/30/12 - 10:34 am
Astellas
Medivation
Enzalutamide
prostate cancer
Will Medivation Be Twice as Good at Half the Price?
Motley Fool
Tue, 09/11/12 - 11:59 am
Medivation
The Final Blow For Dendreon?
Seeking Alpha
Thu, 09/6/12 - 09:30 am
Dendreon
JNJ
Xtandi
Medivation
Medivation Gets Surprise Early Approval For Prostate Cancer Pill
Seeking Alpha
Tue, 09/4/12 - 11:56 am
prostate cancer
Medivation
Xtandi
Medivation 2Q loss narrows on drug payments
Yahoo/AP
Thu, 08/9/12 - 10:18 pm
earnings
Medivation
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Decision Date for Medivation Drug
Yahoo/Zacks
Tue, 08/7/12 - 05:53 pm
Medivation
Astellas
Enzalutamide
prostate cancer
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Sat, 08/4/12 - 11:22 am
Medivation
Astellas
Enzalutamide
prostate cancer
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Yahoo/Fly on the Wall
Tue, 07/24/12 - 09:41 am
Enzalutamide
Medivation
Astellas
prostate cancer
Medivation Inc.: Today's Featured Health Care Leader
The Street
Sat, 07/21/12 - 11:33 am
Medivation
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
Mon, 07/16/12 - 08:48 am
prostate cancer
Medivation
M&A
AbbVie
Astellas
Enzalutamide
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Former Drug Developer Discovers Next-Generation Biotech Stocks
Motley Fool
Sat, 06/23/12 - 11:52 am
Amarin
Ironwood Pharmaceuticals
Medivation
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thu, 05/31/12 - 10:17 am
Medivation
prostate cancer
MDV3100
Astellas

Pages